La seguridad y eficacia de alefacept, el efalizumab etanercept e infliximab en el tratamiento de la psoriasis en placa moderada a severa: un meta-análisis de ensayos controlados aleatorios

Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2010
Cargando información sobre las referencias

CRD SUMMARY:

This review assessed the efficacy and safety of alefacept, efalizumab, etanercept and infliximab for treatment of moderate to severe plaque psoriasis and concluded that all treatments yielded significant improvements over placebo in the short term with an increased risk of adverse events. The authors’ conclusions from this generally well-conducted review reflected the evidence and are likely to be reliable.
Epistemonikos ID: 0e78df53f1e6ff0c52024560d6fb0e8d0c65beb5
First added on: Jun 08, 2012